Intrathecal Trastuzumab as a Potential Cause of Drug-Induced Aseptic Meningitis

Can J Neurol Sci. 2019 May;46(3):358-359. doi: 10.1017/cjn.2019.21. Epub 2019 Mar 25.

Authors

Evangelia Pappa¹, Rosa Conforti², Khê Hoang-Xuan¹, Agusti Alentorn¹

Affiliations

¹ AP-HP,Hôpitaux Universitaires Pitié Salpêtrière -- Charles Foix,Service de Neurologie 2-Mazarin, Paris F-75013,France.
² AP-HP,Hôpitaux Universitaires Pitié Salpêtrière -- Charles Foix,Service d'Oncologie, Paris F-75013,France.

PMID: 30905325
DOI: 10.1017/cjn.2019.21

No abstract available

Keywords: Breast cancer; Intrathecal chemotherapy; Leptomeningeal carcinomatosis.

Publication types

Case Reports
Letter

MeSH terms

Adenocarcinoma / drug therapy
Adenocarcinoma / secondary
Adult
Antineoplastic Agents, Immunological / administration & dosage
Antineoplastic Agents, Immunological / adverse effects*
Breast Neoplasms / drug therapy
Breast Neoplasms / pathology
Female
Humans
Injections, Spinal
Meningeal Carcinomatosis / drug therapy*
Meningeal Carcinomatosis / secondary
Meningitis, Aseptic / chemically induced*
Trastuzumab / administration & dosage
Trastuzumab / adverse effects*

Substances

Antineoplastic Agents, Immunological
Trastuzumab